There is an exploding interest in the development of complex drug composed of hyperlipidemia treatment Rosuvastatin and Ezetimibe
There is an exploding interest in the development of complex drug composed of hyperlipidemia treatment Rosuvastatin and Ezetimibe, with whopping 18 companies involved in developing.
The complex drug with combination of rosuvastatin and ezetimibe makes one’s first appearance in domestic. In parti...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
